Table 1.
Demographic features of the study population
| Control group, n = 44 | Thrombolysis group, n = 42 | p value* | ||
|---|---|---|---|---|
| Sex | Male | 24 (54.5) | 29 (69) | 0.167 |
| Female | 20 (45.5) | 13 (31) | ||
| Age, mean ± SD (range) | 63.3 ± 14.7 (28–86) | 56.4 ± 13.8 (20–69) | 0.001 | |
| Weight, mean ± SD (range) | 73.5 ± 11.6 (40–96) | 55 ± 16.5 (16–86) | 0.611 | |
| Comorbidities | COPD | 4 (9.1) | 3 (7.1) | 0.741 |
| CCF (RHF) | 5 (11.4) | 12 (28.6) | 0.045 | |
| Previous PTE | 0 (0) | 1 (2.4) | 0.303 | |
| Active cancer | 4 (9.1) | 3 (7.1) | 0.741 | |
| Surgery and major trauma | 1 (2.3) | 6 (14.3) | 0.042 | |
| Pregnancy | 0 (0) | 1 (2.4) | 0.303 | |
| Immobilization | 2 (4.5) | 4 (9.5) | 0.365 | |
| Estrogen use | 1 (2.3) | 2 (4.8) | 0.529 | |
| DVT | 5 (11.4) | 4 (9.5) | 0.781 | |
*p value < 0.05, statistically significant. COPD chronic obstructive pulmonary disease, CCF congestive cardiac failure, DVT deep venous thrombosis